Fluoride Ion

Fluoride Ion

SCHEMBL1898517

CCCc1n(C)cc[n+]1C.[F-]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.45
APOBEC3A P31941 2/20 0.42
APOBEC3G Q9HC16 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.32
APAF1 O14727 1/20 0.32
NPC1 O15118 1/20 0.32
PLA2G1B P04054 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL372970 0.98 HDAC8 (0.46) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
SCHEMBL6415433 0.90 HDAC8 (0.41) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
Fluoride Ion SCHEMBL1894046 0.88 HDAC8 (0.45) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
SCHEMBL16673992 0.87 HDAC8 (0.52) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
SCHEMBL372853 0.86 HDAC8 (0.47) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
Sulfuric Acid SCHEMBL21195035 0.86 HTT (0.45) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
Sulfuric Acid SCHEMBL21195036 0.84 HTT (0.47) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
SCHEMBL1835131 0.84 HDAC8 (0.42) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL30980120 0.84 HDAC8 (0.45) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E
SCHEMBL16674097 0.83 HDAC8 (0.48) HDAC8APOBEC3AAPOBEC3GSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698606-B1 FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND USING SAME SUMITOMO CHEMICAL CO (JP) 2013-02-20 EP disclosed
US-7939697-B2 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-10 US disclosed
US-20090287025-A1 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2009-11-19 US disclosed
US-7569703-B2 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-04 US disclosed
US-20070135634-A1 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-06-14 US disclosed
EP-1698606-A1 FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND USING SAME Sumitomo Chemical Company, Limited (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135634-A1 Fluorinating agent and method for producing fluorine-containing compound using the same AFF1, AFF2, AFF4 HDAC8 3030/4885APOBEC3A 3356/4885APOBEC3G 2986/4885
US-20090287025-A1 Fluorinating agent and method for producing fluorine-containing compound using the same AFF1, AFF2, AFF4 HDAC8 3030/4885APOBEC3A 3356/4885APOBEC3G 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.